hydrazine has been researched along with Common Variable Hypogammaglobulinemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Babushok, D; Bagg, A; Hurwitz, SN; Juusola, J; Sklarz, T; Stanley, NL | 1 |
| Barcellini, W; Carrabba, M; Fabio, G | 1 |
2 other study(ies) available for hydrazine and Common Variable Hypogammaglobulinemia
| Article | Year |
|---|---|
Aplastic anemia in a patient with CVID due to NFKB1 haploinsufficiency.
Topics: Anemia, Aplastic; Benzoates; Bone Marrow; Common Variable Immunodeficiency; Cyclosporine; Exome Sequencing; Female; Genetic Predisposition to Disease; Haploinsufficiency; Humans; Hydrazines; Middle Aged; NF-kappa B; NF-kappa B p50 Subunit; Pyrazoles; Signal Transduction | 2020 |
Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia.
Topics: Adult; Benzoates; Common Variable Immunodeficiency; Female; Humans; Hydrazines; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Thrombopoietin | 2016 |